GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (NAS:ILMN) » Definitions » E10

Illumina (Illumina) E10 : $0.68 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Illumina E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Illumina's adjusted earnings per share data for the three months ended in Dec. 2023 was $-1.110. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.68 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Illumina's average E10 Growth Rate was -54.10% per year. During the past 3 years, the average E10 Growth Rate was -41.90% per year. During the past 5 years, the average E10 Growth Rate was -21.30% per year. During the past 10 years, the average E10 Growth Rate was 20.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Illumina was 234.70% per year. The lowest was -41.90% per year. And the median was 44.20% per year.

As of today (2024-04-26), Illumina's current stock price is $122.28. Illumina's E10 for the quarter that ended in Dec. 2023 was $0.68. Illumina's Shiller PE Ratio of today is 179.82.

During the past 13 years, the highest Shiller PE Ratio of Illumina was 3742.00. The lowest was 43.45. And the median was 134.35.


Illumina E10 Historical Data

The historical data trend for Illumina's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina E10 Chart

Illumina Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.09 3.47 4.15 1.48 0.68

Illumina Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.48 1.53 1.36 0.87 0.68

Competitive Comparison of Illumina's E10

For the Diagnostics & Research subindustry, Illumina's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Illumina's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Illumina's Shiller PE Ratio falls into.



Illumina E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Illumina's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1.11/129.4194*129.4194
=-1.110

Current CPI (Dec. 2023) = 129.4194.

Illumina Quarterly Data

per share eps CPI Adj_EPS
201403 0.400 99.695 0.519
201406 0.310 100.560 0.399
201409 0.630 100.428 0.812
201412 1.030 99.070 1.346
201503 0.920 99.621 1.195
201506 0.690 100.684 0.887
201509 0.790 100.392 1.018
201512 0.700 99.792 0.908
201603 0.600 100.470 0.773
201606 0.820 101.688 1.044
201609 0.870 101.861 1.105
201612 0.840 101.863 1.067
201703 2.480 102.862 3.120
201706 0.870 103.349 1.089
201709 1.110 104.136 1.380
201712 0.460 104.011 0.572
201803 1.410 105.290 1.733
201806 1.410 106.317 1.716
201809 1.330 106.507 1.616
201812 1.410 105.998 1.722
201903 1.570 107.251 1.895
201906 1.990 108.070 2.383
201909 1.580 108.329 1.888
201912 1.610 108.420 1.922
202003 1.170 108.902 1.390
202006 0.320 108.767 0.381
202009 1.210 109.815 1.426
202012 1.750 109.897 2.061
202103 1.000 111.754 1.158
202106 1.260 114.631 1.423
202109 2.080 115.734 2.326
202112 0.710 117.630 0.781
202203 0.550 121.301 0.587
202206 -3.400 125.017 -3.520
202209 -24.260 125.227 -25.072
202212 -0.890 125.222 -0.920
202303 0.020 127.348 0.020
202306 -1.480 128.729 -1.488
202309 -4.770 129.860 -4.754
202312 -1.110 129.419 -1.110

Add all the adjusted EPS together and divide 10 will get our e10.


Illumina  (NAS:ILMN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Illumina's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=122.28/0.68
=179.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Illumina was 3742.00. The lowest was 43.45. And the median was 134.35.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Illumina E10 Related Terms

Thank you for viewing the detailed overview of Illumina's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Illumina (Illumina) Business Description

Address
5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Executives
Aimee L Hoyt officer: SVP, Chief People Officer 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Jacob Thaysen director, officer: Chief Executive Officer 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Susan H Tousi officer: SVP Product Development 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Steven Barnard officer: SVP, Chief Technology Officer 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Scott B. Ullem director C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Stephen P Macmillan director 250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Andrew Teno director C/O FIR TREE INC., 55 WEST 46TH STREET, 29TH FLOOR, NEW YORK NY 10036
Alexander Aravanis officer: SVP, Chief Technology Officer 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Scott D Ericksen officer: VP, Chief Accounting Officer 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Charles Dadswell officer: Sr VP & General Counsel 5200 ILLUMINA WAY, SAN DIEGO CA 92122
John Edward Frank officer: Chief Public Affairs Officer 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Phillip G. Febbo officer: SVP Chief Medical Officer C/O GENOMIC HEALTH, INC., 301 PENOBSCOT DRIVE, REDWOOD CITY CA 94063
Carissa Rollins officer: SVP, Chief Information Officer 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Kevin Carl Pegels officer: Chief of Global Operations 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Jay T Flatley officer: President & CEO 9885 TOWNE CENTRE DR, SAN DIEGO CA 92121

Illumina (Illumina) Headlines

From GuruFocus

Q1 2022 Illumina Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Illumina Inc Inaugural ESG Investor Event Transcript

By GuruFocus Research 01-23-2024

Illumina Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Illumina Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2023 Illumina Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024